Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmaceutical Patent Analyst is Scopus-indexed (Q2, CiteScore 3.2). Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2046-8954Verify ISSN ↗2046-8962Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 91 / 191 | 52nd | Q2 |
| Drug Discovery | 109 / 161 | 32nd | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–2024, best quartile Q2, CiteScore 3.2.
Pharmaceutical Patent Analyst is Q2 in Pharmaceutical Science (rank 91 of 191) and Q3 in Drug Discovery (rank 109 of 161), by CiteScore 2025.
Pharmaceutical Patent Analyst is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.2, quartile Q2, 52nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.264, quartile Q3, with an H-index of 23.
Pharmaceutical Patent Analyst is published by Taylor and Francis Ltd. Its print ISSN is 2046-8954 and its online ISSN is 2046-8962.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmaceutical Patent Analyst has an h-index of 26 and a 2-year mean of 2.17 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #80 of 177 Scopus journals in Pharmaceutical Science.
Pharmaceutical Patent Analyst published 24 papers in 2024; its busiest recent year was 2015 with 50. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 87 research articles (2021–2024), authors are most often from India (32.8%), Mexico (13.8%) and Austria (11.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.